Background. Lichen simplex chronicus is a troublesome intractable itchy der
matosis, which may persist despite intensive topical treatments. Recently i
t has been demonstrated that topical aspirin solution with dichloromethane
has a significant antipruritic effect in an experimentally induced itch.
Objective: The aim of this double-blind, crossover placebo trial was to eva
luate the efficacy of this solution in the treatment of lichen simplex chro
nicus.
Methods. Twenty-nine patients with lichen simplex chronicus of at least 3 m
onths' duration that did not respond to topical corticosteroids were random
ized in a double-blind fashion to receive aspirin/dichloromethane solution
in treatment period 1 for 2 weeks followed by placebo in treatment period 2
or placebo followed by aspirin in period 2 with a crossover design after a
2-week washout. The patients rated the pruritus intensity before and durin
g therapy with a visual analog scale; a blinded investigator performed phot
ographic assessment.
Results. A significant therapeutic response was achieved in 11 (46%) of the
patients who completed the study compared with 3 patients (12%) receiving
placebo. Overall, aspirin-treated patients experienced an average decrease
in the visual analog scale of 2.18 +/- 2.86 versus 0.69 +/- 2.31 of those r
eceiving placebo. The difference between the 2 treatments for week 2 was si
gnificant (P =.03).
Conclusion: The study suggests that topical aspirin/dichloromethane might b
e a practical treatment for lichen simplex chronicus.